Fig. from the ribosome (Shan and Walter, 2005). An interaction between SRP and the SRP receptor facilitates targeting of the ribosome-nascent chain complex to the ER, where the ribosome docks onto the Sec61 protein-conducting channel (Osborne et al., 2005). Subsequent translocation is coupled to translation, with the polypeptide passing through the Sec61 channel as it emerges from the ribosomal exit tunnel. The signal sequence is removed during translocation and the translocated mature domain then traffics through the secretory pathway for extracellular secretion. This cotranslational translocation pathway is conserved from bacteria to mammals and is used by most secretory and membrane proteins (Rapoport, 2007). However, secretory proteins smaller than ~100 residues [Sup. Table 1] might complete translation before efficient cotranslational Azilsartan (TAK-536) targeting (Goder et al., 2000;Zimmerman and Mollay, 1986;Zimmermann et al., 1990). This is due to a limited amount of time between when the signal sequence is available for SRP recognition and when the termination codon is reached. Whether such short proteins can access the cotranslational pathway therefore depends on whether this time window is sufficient for SRP recognition, targeting to its receptor, transfer to Rabbit Polyclonal to GANP the Sec61 translocon, and insertion into the channel. If this window is too short, then small proteins would be released into the cytosol and need to enter the ER posttranslationally, a process that is poorly understood in metazoans. Thus, a decisive question in understanding short protein biosynthesis is whether targeting can reasonably occur during its synthesis. Direct estimates Azilsartan (TAK-536) of targeting kinetics in vivo suggest that an average of ten seconds is needed to target even a highly robust SRP-dependent signal (Goder et al., 2000). This means that after Azilsartan (TAK-536) a signal sequence first emerges from the ribosome at ~60 residues of synthesis [Sup. Fig. S1a], targeting may not occur for another ~60 residues (assuming translation at 6 residues/sec). A significant proportion of proteins shorter than ~120 residues would therefore terminate translation before they are targeted. While selective mRNA localization or exceptionally strong translational arrest could conceivably overcome these temporal constraints [Sup. Fig. S1b], these potential mechanisms are poorly characterized. Thus, short precursors may well need to use posttranslational translocation to enter the ER efficiently. Posttranslational ER translocation has been most extensively studied in yeast (Panzner et al., 1995b), where the pathway is utilized by secretory proteins containing modestly hydrophobic signal sequences that cannot engage SRP effectively (Ng, 1996). In this pathway, it is thought that general cytosolic chaperones, most notably of the Hsp70 family, interact with and maintain translocation competence of fully-synthesized substrates in the cytosol (Chirico et al., 1988;Deshaies et al., 1988). Upon release from the chaperones, substrates engage the heptameric Sec complex at the ER. This translocon is composed of the Sec61 complex associated with the Sec62/63/71/72 complex (Deshaies et al., 1991;Panzner et al., 1995a). Substrates that enter the Sec translocon are made accessible to lumenal Kar2 (an Hsp70 family member), which by cycles of ATPase-driven binding and release ratchets the polypeptide across the membrane (Brodsky and Schekman, 1993;Matlack et al., 1999;Panzner et al., 1995a). Thus, the general paradigm is one of substrate chaperoning in the cytosol, engagement of a membrane-bound channel, and biased translocation via a lumenal polypeptide-binding protein. Although all of the components in this pathway are conserved in mammals, such posttranslational translocation has not been studied extensively. Notably, classical yeast posttranslational substrates, such as prepro–factor, can only translocate cotranslationally across mammalian ER membranes (Garcia and Walter, 1988). It was therefore surmised that in higher eukaryotes, the SRP-dependent cotranslational pathway predominantes and has evolved to accommodate a wider range of substrates than in yeast. The main posttranslational models analyzed thus far in mammalian systems have been short secreted proteins (Schlenstedt and Zimmermann, 1987;Schlenstedt et al., 1992; Zimmermann and Mollay, 1986). While they were observed to translocate posttranslationally in vitro, the cellular machinery and.